Maintenance fees coming due
7 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Dec 20, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,680,254 | Engineered Meganucleases Specific for Recognition Sequences in the PCSK9 Gene In force Fee due Dec 20, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | Precision Biosciences, Inc. | In force | Dec 20, 2026 | Jun 21, 2027 | High confidence | |
| US 11,753,630 | Polynucleotides Encoding Engineered Meganucleases Having Specificity for Recognition Sequences in the Dystrophin Gene In force Fee due Mar 12, 2027 Lapses if unpaid Sep 13, 2027 · Medium confidence | Precision Biosciences, Inc. | In force | Mar 12, 2027 | Sep 13, 2027 | Medium confidence | |
| US 11,786,554 | Optimized Engineered Nucleases Having Specificity for the Human T Cell Receptor Alpha Constant Region Gene In force Fee due Apr 17, 2027 Lapses if unpaid Oct 18, 2027 · High confidence | Precision Biosciences, Inc. | In force | Apr 17, 2027 | Oct 18, 2027 | High confidence | |
| US 11,788,077 | Polynucleotides Encoding Optimized Engineered Meganucleases Having Specificity for a Recognition Sequence in the Hepatitis B Virus Genome In force Fee due Apr 17, 2027 Lapses if unpaid Oct 18, 2027 · High confidence | Precision Biosciences, Inc. | In force | Apr 17, 2027 | Oct 18, 2027 | High confidence | |
| US 11,851,680 | Genetically-Modified Immune Cells Comprising a Microrna-Adapted Shrna (SHRNAMIR) In force Fee due Jun 26, 2027 Lapses if unpaid Dec 27, 2027 · High confidence | Precision Biosciences, Inc. | In force | Jun 26, 2027 | Dec 27, 2027 | High confidence | |
| US 11,866,747 | Engineered Meganucleases That Target Human Mitochondrial Genomes In force Fee due Jul 9, 2027 Lapses if unpaid Jan 10, 2028 · Medium confidence | Precision Biosciences, Inc. | In force | Jul 9, 2027 | Jan 10, 2028 | Medium confidence | |
| US 10,603,363 | Treatment of Retinitis Pigmentosa Using Engineered Meganucleases In force Fee due Sep 30, 2027 Lapses if unpaid Mar 31, 2028 · High confidence | Precision Biosciences, Inc. | In force | Sep 30, 2027 | Mar 31, 2028 | High confidence |
7 of 7 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.